Mapping human bone marrow yields new tool, insights on blood cancer

Weill Cornell Medicine investigators have developed a new AI-based method to assess patients with a form of blood cancer called myelodysplastic neoplasms. The method, published June 30 in Leukemia, compares the physical locations and morphometric (size and shape) characteristics of every hematopoietic cell in a patient's bone marrow sample with those in healthy bone marrow to generate a score that reflects disease severity.

Raccontata damedicalxpress.com